The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 6,501–6,600 of 31,469
Cupisti, S., Giltay, E. J., Gooren, L. J., Kronawitter, D., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.048 · Cited by 55
Petrone, A., Zavarella, S., Caiazzo, A. M., Leto, G., Spoletini, M., Potenziani, S., Osborn, J. F., Vania, A., & Buzzetti, R. (2006) · Obesity · doi:10.1038/oby.2006.172 · Cited by 55
Visfatin levels and intima-media thicknesses in rheumatic diseases
Özgen, M., Koca, S. S., Aksoy, K., Dağlı, N., Üstündağ, B., & Işık, A. T. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1649-2 · Cited by 55
Dewailly, D., Alebi, M., Duhamel, A., & Stojanovi, N. (2014) · Human Reproduction · doi:10.1093/humrep/deu242 · Cited by 55
The association of dyslipidemia and obesity with glycated hemoglobin
Sheth, J. J., Shah, A., Sheth, F. J., Trivedi, S. N., Nabar, N., Shah, N., Thakor, P., & Vaidya, R. A. (2015) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-015-0004-6 · Cited by 56
Kizer, J. R., Benkeser, D. C., Arnold, A. M., Djoussé, L., Zieman, S. J., Mukamal, K. J., Tracy, R. P., Mantzoros, C. S., Siscovick, D. S., Gottdiener, J. S., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2103 · Cited by 54
Effect of Ramadan fasting on glycemic control in patients with Type 2 diabetes.
Norouzy, A., Mohajeri, S. M. R., Shakeri, S., Yari, F., Sabery, M., Philippou, E., Varasteh, A.-R., & Nematy, M. (2012) · PubMed · doi:10.3275/8015 · Cited by 55
Physical activity and cardiovascular risk factors in childhood cancer survivors
Slater, M. E., Ross, J. A., Kelly, A. S., Dengel, D. R., Hodges, J. S., Sinaiko, A. R., Moran, A., Lee, J., Perkins, J. L., Chow, L. S., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25276 · Cited by 58
The response to short‐term intensive insulin therapy in type 2 diabetes
Retnakaran, R. R., Yakubovich, N., Qi, Y., Opsteen, C., & Zinman, B. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01129.x · Cited by 57
Mango modulates body fat and plasma glucose and lipids in mice fed a high-fat diet
Lucas, E. A., Li, W., Peterson, S., Brown, A., Kuvibidila, S. R., Perkins-Veazie, P. M., Clarke, S. L., & Smith, B. J. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511002066 · Cited by 57
Bosy‐Westphal, A., Wolf, A., Bührens, F., Hitze, B., Czech, N., Mönig, H., Selberg, O., Settler, U., Pfeuffer, M., Schrezenmeir, J., et al. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1695 · Cited by 58
Geliebter, A., Astbury, N. M., Aviram-Friedman, R., Yahav, E., & Hashim, S. A. (2014) · Journal of Nutritional Science · doi:10.1017/jns.2014.51 · Cited by 55
Thomas, N., Grunnet, L. G., Poulsen, P., Christopher, S., Spurgeon, R., Inbakumari, M., Livingstone, R. S., Alex, R., Mohan, V. R., Antonisamy, B., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0870 · Cited by 55
Shah, R. D., Matthews, G. J., Shah, R. Y., McLaughlin, C., Chen, J., Wolman, M., Master, S. R., Chai, B., Xie, D., Rader, D. J., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.01.021 · Cited by 55
Kim, H. Y., Kim, C. W., Park, C.-H., Choi, J. Y., Han, K., Merchant, A. T., & Park, Y. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60030-3 · Cited by 54
Li, J., Armstrong, C. L. H., & Campbell, W. W. (2016) · Nutrients · doi:10.3390/nu8020063 · Cited by 60
Song, H., Lai, J., Tang, Q., & Zheng, X. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.01.011 · Cited by 56
Meixner, L., Hoffman, J., Zwickl, B., Goldman, M. H., Whitely, K., Conrad, A., Fichtenbaum, C. J., Hyc, F., Spitz, T., Shaw, D. D., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100802 · Cited by 55
Mangge, H., Zelzer, S., Prüller, F., Schnedl, W. J., Weghuber, D., Enko, D., Bergsten, P., Haybaeck, J., & Meinitzer, A. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.02.007 · Cited by 58
Retnakaran, R. R., Ye, C., Kramer, C. K., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1402 · Cited by 56
Serum Bilirubin Level Is Inversely Associated With Nonalcoholic Steatohepatitis in Children
Puri, K., Nobili, V., Melville, K., Corte, C. D., Sartorelli, M. R., López, R., Feldstein, A. E., & Alkhouri, N. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318291fefe · Cited by 55
Nishida, Y., Ide, Y., Okada, M., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12748 · Cited by 55
Are your engineers talking to one another when they should?
Sosa, M. E., Eppinger, S. D., & Rowles, C. M. (2007) · PubMed · Cited by 55
Vilela, B. S., Vasques, A. C. J., Cassani, R. S. L., Forti, A. C. E., Pareja, J. C., Tambascia, M. A., BRAMS Investigators, & Geloneze, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158751 · Cited by 55
Gugliucci, A., Lustig, R. H., Caccavello, R. J., Erkin‐Cakmak, A., Noworolski, S. M., Tai, V., Wen, M., Mulligan, K. M., & Schwarz, J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.048 · Cited by 56
Han, S. J., Kim, H. J., Kim, D. J., Lee, K. W., & Cho, N. H. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.004 · Cited by 57
Ogura, K., Ogura, M., Shoji, T., Sato, Y., Tahara, Y., Yamano, G., Sato, H., Sugizaki, K., Fujita, N., Tatsuoka, H., et al. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03424 · Cited by 55
Naranjo, A., Ojeda, S., Mendoza, D., Francisco, F., Quevedo, J. C., & Erausquin, C. (2007) · PubMed · Cited by 55
Effects of crocin on experimental obesity and type-2 diabetes
Hazman, Ö., Aksoy, L., & Büyükben, A. (2016) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1506-108 · Cited by 55
Blüher, S., Käpplinger, J., Herget, S., Reichardt, S., Böttcher, Y., Grimm, A., Kratzsch, J., & Petroff, D. (2017) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2016.11.015 · Cited by 51
Petersen, P. S., Lei, X., Wolf, R. M., Rodriguez, S., Tan, S. Y., Little, H. C., Schweitzer, M., Magnuson, T. H., Steele, K. E., & Wong, G. W. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00344.2016 · Cited by 56
Rosqvist, F., Bjermo, H., Kullberg, J., Johansson, L. O. M., Michaëlsson, K., Ahlström, H. K., Lind, L., & Risérus, U. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0445-2 · Cited by 55
Buscemi, S., Chiarello, P., Buscemi, C., Corleo, D., Massenti, M. F., Barile, A. M., Rosafio, G., Maniaci, V., Settipani, V., Cosentino, L., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9294038 · Cited by 55
Carstensen‐Kirberg, M., Kannenberg, J. M., Huth, C., Meisinger, C., Köenig, W., Heier, M., Peters, A., Rathmann, W., Roden, M., Herder, C., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0591-x · Cited by 55
Wallenius, V., Dirinck, E. L., Fändriks, L., Maleckas, A., le Roux, C. W., & Thorell, A. (2017) · Obesity Surgery · doi:10.1007/s11695-017-3061-3 · Cited by 58
Long Non-Coding RNAs Associated with Metabolic Traits in Human White Adipose Tissue
Gao, H., Kerr, A. G., Jiao, H., Hon, C.-C., Rydén, M., Dahlman, I. A., & Arner, P. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.03.010 · Cited by 56
Bosquet, A., Girona, J., Guaita‐Esteruelas, S., Heras, M., Saavedra-García, P., Martínez-Micaelo, N., Masana, L., & Rodríguez‐Calvo, R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.03.004 · Cited by 56
Karbaschian, Z., Mokhtari, Z., Pazouki, A., Kabir, A., Hedayati, M., Moghadam, S. S., Mirmiran, P., & Hekmatdoost, A. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3280-2 · Cited by 55
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
Wasilewska, N., Bobrus‐Chociej, A., Harasim‐Symbor, E., Tarasów, E., Wojtkowska, M., Chabowski, A., & Lebensztejn, D. M. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0855-9 · Cited by 56
Beals, J. W., Skinner, S. K., McKenna, C. F., Poozhikunnel, E. G., Farooqi, S. A., van Vliet, S., Martinez, I. G., ULANOV, A. V., Li, Z., Paluska, S. A., et al. (2018) · The Journal of Physiology · doi:10.1113/jp276210 · Cited by 56
Muscle Fitness Cut Points for Early Assessment of Cardiovascular Risk in Children and Adolescents
Castro‐Piñero, J., Pérez‐Bey, A., Cuenca‐García, M., Cabanas-Sanchez, V., Gómez-Martínez, S., Veiga, O. L., Marcos, A., Ruiz, J. R., Marcos, A., Gomez-Martinez, S., et al. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.10.026 · Cited by 54
Attia, R. T., Abdel–Mottaleb, Y., Abdallah, D. M., El-Abhar, H. S., & El‐Maraghy, N. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.079 · Cited by 57
Chen, H., Nie, Q., Hu, J., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801008 · Cited by 55
Wang, B., Li, M., Zhao, Z., Lu, J., Chen, Y., Xu, Y., Xu, M., Wang, W., Wang, T., Bi, Y., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4898-x · Cited by 55
Vaghef‐Mehrabany, E., Ranjbar, F., Jafarabadi, M. A., Hosseinpour-Arjmand, S., & Ebrahimi‐Mameghani, M. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1630985 · Cited by 55
Perticone, M., Maio, R., Sciacqua, A., Suraci, E., Pinto, A., Pujia, R., Zito, R., Gigliotti, S., Sesti, G., & Perticone, F. (2019) · Molecules · doi:10.3390/molecules24132499 · Cited by 57
Tinius, R. A., Blankenship, M. M., Furgal, K. E., Cade, W. T., Pearson, K. J., Rowland, N. S., Pearson, R. C., Hoover, D. L., & Maples, J. M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154142 · Cited by 54
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01469-5 · Cited by 57
Jung, C., Rhee, E., Kwon, H., Chang, Y., Ryu, S., & Lee, W. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.1.165 · Cited by 55
Hsieh, Y., Joo, S. K., Koo, B. K., Lin, H., & Kim, W. K. (2020) · Liver International · doi:10.1111/liv.14719 · Cited by 57
Elabi, O. F., da Cunha, J. P. M. C. M., Gaceb, A., Fex, M., & Paul, G. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02218-8 · Cited by 58
Wang, Y., Lin, M., Gao, X., Pedram, P., Jian-ling, D., Chandurkar, V., Gulliver, W. P., Zhang, H., & Sun, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174149 · Cited by 56
Yusof, B. N. M., Talib, R. A., Kamaruddin, N. A., Karim, N. A. B., Chinna, K., & Gilbertson, H. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00984.x · Cited by 55
Batterham, M. J., Garsia, R. J., & Greenop, P. A. (2000) · AIDS · doi:10.1097/00002030-200008180-00020 · Cited by 55
Ambulatory blood pressure monitoring in obese children: role of insulin resistance
Marcovecchio, M. L., Patricelli, L., Zito, M., Capanna, R., Ciampani, M., Chiarelli, F., & Mohn, A. (2006) · Journal of Hypertension · doi:10.1097/hjh.0b013e328010918b · Cited by 55
Björck, J., Hellgren, M. I., Råstam, L., & Lindblad, U. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.010 · Cited by 55
Ismael, M. A., Talbot, S., Carbonneau, C. L., Beausejour, C. M., & Couture, R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.006 · Cited by 55
Desai, M., Cull, C. A., Horton, V. A., Christie, M. R., Bonifacio, E. E., Lampasona, V., Bingley, P. J., Lévy, J., Mackay, I. R., Zimmet, P., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0745-6 · Cited by 55
Lotz, T., Chase, J. G., McAuley, K. A., Shaw, G. M., Docherty, P. D., Berkeley, J. E., Williams, S., Hann, C. E., & Mann, J. I. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400616 · Cited by 55
Colonic fermentation from lactulose inhibits lipolysis in overweight subjects
Ferchaud‐Roucher, V., Pouteau, E. B., Piloquet, H., Zaïr, Y., & Krempf, M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2004 · Cited by 55
Lemieux, C., Picard, F., Labrie, F., Richard, D., & Deshaies, Y. (2003) · Obesity Research · doi:10.1038/oby.2003.65 · Cited by 55
Helge, J. W., Lundby, C., Christensen, D. L., Langfort, J., Messonnier, L. A., Zacho, M., Andersen, J. L., & Saltin, B. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00218 · Cited by 55
Plasma visfatin levels in normal weight women with polycystic ovary syndrome
Panidis, D., Farmakiotis, D., Rousso, D., Katsikis, I., Delkos, D., Piouka, A., Gerou, S., & Diamanti‐Kandarakis, E. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.05.014 · Cited by 55
Body composition and metabolic factors in obese children and adolescents
Tershakovec, A. M., Kuppler, K. M., Zemel, B. S., et al. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802185 · Cited by 55
Chandalia, M., Grundy, S. M., ADAMS-HUET, B. A., et al. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.11.003 · Cited by 55
Predictors of insulin sensitivity in Type 2 diabetes mellitus
Bonora, E., Targher, G., Alberiche, M., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Poli, M., Zenari, L., Raffaelli, A., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00764.x · Cited by 54
Effect of obesity on inflammatory markers and renal functions
Cındık, N., Baskın, E., Ağras, P. I., Kınık, S. T., Turan, M., & Saatçi, U. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb01845.x · Cited by 55
Increased cardiovascular risk markers in obesity are associated with body adiposity: Role of leptin
Gómez‐Ambrosi, J., Salvador, J., Silva, C., Pastor, C., Rotellar, F., Gil, M., Cienfuegos, J. A., & Frühbeck, G. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-02-0079 · Cited by 55
Plasma FGF-21 levels in type 2 diabetic patients with ketosis
Li, L., Yang, G., Ning, H., Yang, M., Liu, H., & Chen, W. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.012 · Cited by 55
Bing, C., Ambye, L., Fenger, M., Jørgensen, T., Borch‐Johnsen, K., Madsbad, S., & Urhammer, S. A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01575.x · Cited by 55
Shikuma, C. M., Yang, Y., Glesby, M. J., Meyer, W. A., Tashima, K. T., Ribaudo, H. J., Webb, N., Bastow, B., Kuritzkes, D. R., & Gulick, R. M. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318031d5a0 · Cited by 55
Hanley, A. J., Zinman, B., Sheridan, P., Yusuf, S., Gerstein, H. C., & for the Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators (2009) · Diabetes Care · doi:10.2337/dc09-1579 · Cited by 55
Theodorakis, M. J., Carlson, O. D., Muller, D. C., & Egan, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1692 · Cited by 56
Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome
Sir‐Petermann, T., Echiburú, B., Maliqueo, M. A., Crisosto, N., Sanchez, F., Hitschfeld, C., Cárcamo, M., Amigo, P., & Pérez‐Bravo, F. (2007) · Human Reproduction · doi:10.1093/humrep/dem090 · Cited by 55
Metabolic syndrome and renal sodium handling in three ethnic groups living in England
Barbato, A., Cappuccio, F. P., Folkerd, E. J., Strazzullo, P., Sampson, B., Cook, D. G., & Alberti, K. G. M. M. (2004) · Diabetologia · doi:10.1007/s00125-003-1260-z · Cited by 55
Hero, M., Ankarberg-Lindgren, C., Taskinen, M.-R., & Dunkel, L. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02226 · Cited by 55
Englund‐Ögge, L., Brohall, G., Behre, C. J., Schmidt, C. B., & Fagerberg, B. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1782 · Cited by 55
Enhanced muscle insulin receptor autophosphorylation with short-term aerobic exercise training
YOUNGREN, J. F., Keen, S., Kulp, J. L., Tanner, C. J., Houmard, J. A., & Goldfine, I. D. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.3.e528 · Cited by 55
Lim, S. K., Lee, H., Kimm, K.-C., Park, C., Shin, C., & Cho, N. H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.02.020 · Cited by 55
Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients
Mulè, G., Cottone, S., Mongiovì, R., Cusimano, P., Mezzatesta, G., Seddio, G., Volpe, V., Nardi, E., Andronico, G., Piazza, G., et al. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.03.005 · Cited by 55
Insulin resistance as putative cause of chronic renal transplant dysfunction
de Vries, A. P. J., Bakker, S. J. L., van Son, W. J., van der Heide, J. J. H., THE, T. H., de Jong, P. E., & Gans, R. O. B. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00034-9 · Cited by 55
James, A. P., Watts, G. F., Barrett, P. H. R., Smith, D., Pal, S., Chan, D. C., & Mamo, J. C. L. (2003) · Metabolism · doi:10.1053/meta.2003.50032 · Cited by 54
Messier, V., Karelis, A. D., Lavoie, M.-E., Brochu, M., Faraj, M., Strychar, I., & Rabasa-Lhoret, R. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-135 · Cited by 54
Meijssen, S., Cabezas, M. C., Twickler, T. B., Jansen, H., & Erkelens, D. W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32015-0 · Cited by 53
Modulation of midbrain neurocircuitry by intranasal insulin
Edwin Thanarajah, S., Iglesias, S., Kuzmanovic, B., Rigoux, L., Stephan, K. E., Brüning, J. C., & Tittgemeyer, M. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.03.050 · Cited by 55
Auriemma, R. S., Galdiero, M., Vitale, P., Granieri, L., Calzo, F. L., Salzano, C., Ferreri, L., Pivonello, C., Cariati, F., Coppola, G., et al. (2015) · Neuroendocrinology · doi:10.1159/000371851 · Cited by 55
Kramer, C. K., Zinman, B., Choi, H., Connelly, P. W., & Retnakaran, R. R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2725 · Cited by 54
Zhu, B., Ma, C., Chaiard, J., & Shi, C. (2017) · Sleep And Breathing · doi:10.1007/s11325-017-1554-x · Cited by 53
Khella, M. S., Hamdy, N. Μ., Amin, A. I., & EL-Mesallamy, H. O. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0461-0 · Cited by 57
Mazidi, M., Kengne, A. P., Mikhailidis, D. P., et al. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0571-x · Cited by 54
Xiao, M., Chen, G., Zeng, F., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1678-1 · Cited by 54
Obesity and insulin resistance in children
Tagi, V. M., & Chiarelli, F. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000913 · Cited by 58
Xiao, Q., Qian, J., Evans, D. S., Redline, S. S., Lane, N. E., Ancoli‐Israel, S., Scheer, F. A. J. L., & Stone, K. L. (2020) · Diabetes Care · doi:10.2337/dc20-0557 · Cited by 53
Grimaudo, S., Bartesaghi, S., Rametta, R., Marra, F., Mancina, R. M., Pihlajamäki, J., Kakol‐Palm, D., Andréasson, A., Dongiovanni, P., Fracanzani, A. L., et al. (2020) · Liver International · doi:10.1111/liv.14711 · Cited by 54
Chang, Y., Kim, C. K., Kim, M., Seo, W., & Oh, K. (2021) · Scientific Reports · doi:10.1038/s41598-020-80315-z · Cited by 54
Kahleová, H., McCann, J., Alwarith, J., Rembert, E., Tura, A., Holubkov, R., & Barnard, N. D. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.05.015 · Cited by 55
Chun, H. S., Kim, M. N., Lee, J. S., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., & Kim, S. U. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12754 · Cited by 54
Song, S., Zhang, Y., Qiao, X., Duo, Y., Xu, J., Peng, Z., Zhang, J., Chen, Y., Nie, X., Sun, Q., et al. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13905 · Cited by 63
Zhang, Y.-T., Zeeshan, M., Su, F., Qian, Z.-M., Geiger, S. D., McMillin, S. E., Wang, Z.-B., Dong, P.-X., Ou, Y.-Q., Xiong, S.-M., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106913 · Cited by 56
Zeng, J., Qin, L., Jin, Q., Yang, R., Ning, G., Su, Q., YANG, Z. K., & Fan, J. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.01.006 · Cited by 55
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
